Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

NovaBev Group reported for 6 months of 2024 by IFRS

8/22/24 BELU

Renaissance Insurance to allocate ₽2 billion for dividends

8/22/24 RENI

Board of Directors of INARCTICA recommended dividends

8/22/24 AQUA

Renaissance Insurance reported for 6 months of 2024 by IFRS

8/22/24 RENI

CarMoney reported for 6 months of 2024 by IFRS

8/22/24 CARM

SPB Exchange placed the first CFAs

8/21/24 SPBE

Cian has reported for 6 months of 2024

8/21/24 CIAN

Sminex buys Ingrad

8/21/24 INGR

Capital Group has almost completely withdrawn from the capital of Moscow Exchange

8/21/24 MOEX

Ozon launches the first phase of hub in the Orenburzhye

8/21/24 OZON